Compare Illumina, Inc. (ILMN) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs PayPal Holdings, Inc. — how do they compare? Illumina, Inc. trades at $191.43 (market cap $27.94B), while PayPal Holdings, Inc. trades at $55.71 (market cap $50.12B). The key difference: PayPal Holdings, Inc. is the larger of the two by market cap, and PayPal Holdings, Inc. pays a 0.99% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | PYPL | |
|---|---|---|
Market Cap | $27.94B | $50.12B |
Sector | Health | Financials |
52-Week High | $194.33 | $78.22 |
52-Week Low | $91.00 | $39.08 |
Enterprise Value | $29.33B | $50.19B |
Dividend Yield | — | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
PayPal (PYPL) trades at $56.78, up 0.38% with strong technical momentum as the stock approaches resistance near $57-$59 following a $53 billion takeover bid from Stripe and Advent International. The company shows solid fundamentals with 2025 revenue of $33.17B, net income of $5.23B (15% margin), and attractive valuation metrics including a P/E of 10.6 and P/S of 1.6. Recent earnings beat expectations in Q1 2026 with EPS of $1.34 versus $1.27 expected.
The acquisition offer at $60.50 per share provides near-term upside potential, though the board considers it undervalued. Key risks include regulatory hurdles for the deal and competitive pressures in digital payments. Analyst sentiment is mixed with 36% buy ratings but a consensus price target of $50.80 below current levels, suggesting cautious optimism amid takeover speculation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
